These findings suggest that TRIM65 may play a role regulating of AKI through the targeting of VDAC1‐dependent mitochondrial function, offering potential avenues for the development of new drug targets and strategies for the treatment of AKI. This evidence concerns the gene TRIM65 and acute kidney injury.